Punicalagin attenuates ventricular remodeling after acute myocardial infarction via regulating the NLRP3/caspase-1 pathway.

CONTEXT: Punicalagin has myocardial protection; the mechanism of punicalagin on ventricular remodeling (VR) after acute myocardial infarction (AMI) remains unclear. OBJECTIVE: These studies explore the role and mechanism of punicalagin in preventing and treating VR after AMI. MATERIALS AND METHODS: Molecular docking was used to predict the targets of punicalagin. After 2 weeks of AMI model, the SD rats were randomly divided into model, and punicalagin (200, 400 mg/kg, gavage) groups for 4 weeks. Thoracotomy with perforation but no ligature was performed on rats in control group. The protein expression of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3), apoptosis speck-like protein (ASC), caspase-1, gasdermin D (GSDMD), and GSDMD-N, the mRNA expression of NLRP3, caspase-1, GSDMD, interleukin-1ß (IL-1ß) and IL-18 were evaluated. RESULTS: Punicalagin had binding activities with NLRP3 (Vina score, -5.8), caspase-1 (Vina score, -6.7), and GSDMD (Vina score, -6.7). Punicalagin could improve cardiac function, alleviate cardiac pathological changes, minimize the excessive accumulation of collagen in the left ventricular myocardium (p < 0.01), and inhibit cardiomyocyte apoptosis (p < 0.01). Furthermore, punicalagin could inhibit the overexpression of NLRP3, caspase-1, and GSDMD via immunohistochemistry (p < 0.01). Punicalagin inhibited the protein levels of NLRP3, caspase-1, ASC, GSDMD, and GSDMD-N (p < 0.05, p < 0.01). Punicalagin reduced the mRNA expression of NLRP3, caspase-1, GSDMD, IL-1ß and IL-18 (p < 0.05, p < 0.01). CONCLUSIONS: Punicalagin may provide a useful treatment for the future myocardial protection.

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity.

CONTEXT: Shengmai injection (SMI) has been used to treat heart failure. OBJECTIVE: This study determines the molecular mechanisms of SMI against cardiotoxicity caused by doxorubicin (DOX). MATERIALS AND METHODS: In vivo, DOX (15 mg/kg) was intraperitoneally injected in model, Dex (dexrazoxane), SMI-L (2.7 mL/kg), SMI-M (5.4 mL/kg), and SMI-H (10.8 mL/kg) for 7 consecutive days. Hematoxylin-eosin (HE) and Masson staining were used to evaluate histological changes, and cardiomyocyte apoptosis was identified using TdT-mediated dUTP nick-end labelling (TUNEL). Enzymatic indexes were determined. mRNA and protein expressions were analysed through RT-qPCR and Western blotting. In vitro, H9c2 cells were divided into control group, model group (2 mL 1 µM DOX), SMI group, ML385 group, and SMI + ML385 group, the intervention lasted for 24 h. mRNA and protein expressions were analysed. RESULTS: SMI markedly improved cardiac pathology, decreased cardiomyocyte apoptosis, increased creatine kinase (CK), lactate dehydrogenase (LDH), malondialdehyde (MDA), decreased superoxide dismutase (SOD). Compared with the model group, the protein expression of nuclear factor erythroid2-related factor 2 (Nrf2) (SMI-L: 2.42-fold, SMI-M: 2.67-fold, SMI-H: 3.07-fold) and haem oxygenase-1(HO-1) (SMI-L: 1.64-fold, SMI-M: 2.01-fold, SMI-H: 2.19-fold) was increased and the protein expression of kelch-like ECH-associated protein 1 (Keap1) (SMI-L: 0.90-fold, SMI-M: 0.77-fold, SMI-H: 0.66-fold) was decreased in SMI groups and Dex group in vivo. Additionally, SMI dramatically inhibited apoptosis, decreased CK, LDH and MDA levels, and enhanced SOD activity. Our results demonstrated that SMI reduced DOX-induced cardiotoxicity via activation of the Nrf2/Keap1 signalling pathway. CONCLUSIONS: This study revealed a new mechanism by which SMI alleviates DOX-induced 45 cardiomyopathy by modulating the Nrf2/Keap1 signal pathway.

[Review of Comprehensive Evaluation System of Vehicle Pollution and Carbon Synergistic Reduction].

Vehicle emissions have become one of the most important air pollution sources in China. Promoting vehicle synergistic reduction of pollution and carbon is the key to improving regional environmental quality and achieving the carbon peaking and carbon neutrality goals. Building a collaborative evaluation system and comprehensive quantitative method is an important prerequisite for scientific and effective implementation of vehicle pollution and carbon synergistic reduction. Therefore, it is significant to extensively review existing synergistic evaluation methods and comprehensive environmental benefit accounting methods of atmospheric pollution and carbon reduction. On this basis, we focused on vehicle emission characteristics, systematically organized the key indicators of vehicle collaborative reduction evaluation, and summarized quantitative methods of policy effects from three aspects (health exposure cost, climate change cost, and pollutant control cost), to provide theoretical support for policy formulation, schemes selection, and their effect evaluation. For the future, the assessment of vehicle coordinated emission reduction is proposed to accelerate unified index system establishment, deeply analyze the spatial distribution of environmental benefits, focus on the pollution transfer caused by vehicle electrification, and explore the quantitative methods of climate change cost due to extreme weather.

[Chemical Component of Particulate Matters and VOCs Characteristics During Vehicle Brake Processes].

Six sets of brake systems were tested using a brake dynamometer, and the brake wear particles (BWPs) and volatile organic compounds (VOCs) were collected during the braking process. In total, 39 elements, 12 water-soluble ions, 7 carbon components, and 18 polycyclic aromatic hydrocarbons (PAHs) in BWPs were extracted and detected, and 74 VOCs in gas samples were analyzed. The average mass fractions of 12 inorganic elements (i.e., Sb, Mg, Cu, Zn, Ti, Ca, Si, Zr, K, Ba, Al, and Fe) with higher contents in PM2.5 and PM10 were 43.4% and 40.3%, respectively, and the average mass fraction of Fe was the highest, accounting for 16.6% and 13.1% of PM2.5 and PM10, respectively. The average mass fractions of the 12 water-soluble ions in PM2.5 and PM10 were 16.5% and 12.6%, respectively, and NO3-, SO42-, and Ca2+ were the ions with high contents. The average mass fraction of total carbon (TC) in PM2.5 and PM10 were 21.9% and 18.1%, respectively, and the average mass fraction of organic carbon (OC) was approximately five times that of elemental carbon (EC). There were six types of PAHs with a detection rate greater than 50%, among which naphthalene (Nap) was the most abundant. The average mass concentration of 74 VOCs was 316.04 µg·m-3, of which the aromatic hydrocarbon had the highest mass concentration. The compositions of BWPs and VOCs emitted by the six sets of brake systems were quite different, which was mainly determined by the brand and raw materials of the brake pads.

The Protective Effect of Sheng Mai Yin on Diabetic Cardiomyopathy via NLRP3/Caspase-1 Pathway.

Sheng Mai Yin (SMY) has therapeutic effects on myocardial infarction (MI), heart failure (HF), diabetic cardiomyopathy (DCM), and myocarditis. To study whether SMY can relieve pyroptosis and play a protective role in diabetic cardiomyopathy, a molecular docking technique was used to predict the possible mechanism of SMY against DCM. Then, a DCM rat model was induced by intraperitoneal injection of streptozotocin (STZ), divided into 5 groups: the DM group (model), SMY-L group (2.7 mL/kg SMY), SMY-M group (5.4 mL/kg SMY), SMY-H group (10.8 mL/kg SMY), and Met group (120 mg/kg metformin). Rats in the CTL group (control) and DM group were given normal saline. After 8 weeks, the levels of blood glucose, lipids, and myocardial enzymes were detected according to the kit instructions. Cardiac function was detected by echocardiography. HE and Masson were used to observing the pathological changes, collagen deposition, and collagen volume fraction (CVF). The apoptosis rate of cardiomyocytes was determined by Tunel. The IL-1ß level was determined by ELISA and RT-PCR. The expressions of NLRP3, caspase-1, and GSDMD were measured using RT-PCR and Western blotting. The docking results suggested that SMY may act on NLRP3 and its downstream signal pathway. The in vivo results showed that SMY could reduce blood glucose and lipid levels, improve heart function, improve histopathological changes and myocardial enzymes, and alleviate cardiomyocyte apoptosis and myocardial fibrosis. SMY inhibited the mRNA and protein expressions of NLRP3, ASC, Caspase-1, and GSDMD and IL-1ß production. SMY can reduce DCM by regulating the NLRP3/caspase-1 signaling pathway, providing a new research direction for the treatment of DCM.

Changes in nitrate accumulation mechanisms as PM2.5 levels increase on the North China Plain: A perspective from the dual isotopic compositions of nitrate.

Nitrate (NO3-) has become recognized as the most important water-soluble ion in fine particulate (PM2.5), and has been proposed as a driving factor for regional haze formation. However, nitrate formation mechanisms are still poorly understood. In this study, PM2.5 samples were collected from September 2017 to August 2018 in Shijiazhuang, a city located on the North China Plain, and NO3-concentration, δ18O-NO3- and δ15N-NO3- values in PM2.5 were analyzed. NO3- concentrations increased as PM2.5 levels increased during both polluted and non-polluted days over the entire year. δ18O-NO3- values during cold months (63.5-103‰) were higher than those during warm months (50.3-85.4‰), these results suggested that the nitrate formation pathways shifted from the NO2 + OH (POH) in warm months to the N2O5 + H2O (PN2O5) and NO3 + VOCs (PNO3) pathways in cold months. Especially during cold months, δ18O-NO3- values increased from 65.2-79.9‰ to 80.7-96.2‰ when PM2.5 increased from ∼25 to >100 µg/m3, but when PM2.5 > 100 µg/m3, there were relatively small variations in δ18O-NO3-. These results suggested that nitrate formation pathways changed from POH to PN2O5 and PNO3 pathways when PM2.5 < 100 µg/m3, but that PN2O5 and PNO3 dominated nitrate production when PM2.5 > 100 µg/m3. Higher δ15N-NO3- values in warm months (-11.8-13.8‰) than in cold months (-0.7-22.6‰) may be attributed to differences in NOx emission sources and nitrogen isotopic fractionation among NOx and NO3-. These results provide information on the dual isotopic compositions of nitrate to understand nitrate formation pathways under different PM2.5 levels.